<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 200 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page199.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=200">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 200 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 200</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=200"><img src="../thumb/200.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>166 / 2020-04              Respiratory System / Ear, Nose and Throat - 10.4.2 / 10.4.3 / 10.4.4 / 10.5 / 10.6 / 11 / 11.1 . 11.1.1 / 11.1.2
   Contraindications: Pregn.& lactat., safety & effic. in paeds.pts.  less than 8 hrs of age. In high risk infts.up to 4 dos.may be admin.in   AVAMYS, (Aspen Pharmacare) GSK [P/S] &
   und.2 yrs.not est.for 4 mg chew tabs./ in childr.und.6 yrs.for 5 mg   48 hours, 1st dos.15 mins.post.part., up to 3 addit.dos.at 6 hr.interv.   Fluticasone furoate.
   & in childr.und. 15 yrs.for 10 mg tabs.10 mg tabs.also in heredit.   Each dos.given in 4 equal subdos.instil.intratracheally into 4 lung   Indications: Adults & adolesc.12 yrs & over: Season.& perenn.
   galact.intol.condits.        quadrants. For instillat.proced.see lit.  allerg.rhinit.includ.ocul.sympts. Childr.2-11 yrs: Nasal sympts.of
   Side effects: Asthen., fatig., fev., incr.sweat., abdom.pain., trauma,   Side effects: Trans.bradycard.  season.& perenn. allerg.rhinit.
   dyspeps., infect. gastroenterit., dent.pain, diarrh., thirst, CNS effs.,   Special precautions: Complicat.relat.to prematurity (eg.patent   (S4) NAS.SPRAY. 41/21.5.1/0968.
   nas.congest., cough, influenza, rash, incr.ALT/AST, pyuria, system.eo-  ductus arterosus) are not prevent., pronoun.improvem.in oxygenat.  27,5 µg/50 µl spray
   sinophil.pres.with clinic.vasculit. feat., incr.bleed.tendenc., hypersens.  requir. changes in mechanic. ventilat.parameters usual. occur within   712866-001: 120 met.sprays/bottle, R228,97
   reacts.incl. anaphylax./ angioed.& hepat.eosinophil.infiltrat., psych.  minutes of treatm., admin.in sev. hypotens. not studied.  Dosage: Admin.by intranasal route only. For full therapeut. benef.
   effs.incl.aggress.& suicid.think.& behav., paraesthes./ hypoesthes.,   reg.use essent. It may take sev.days to achieve max. benef. No ex-
   seiz., palpitat., chest pain, epistax., N&V, cholelstat.hepatit., prurit., ur-  per.in childr. und.2 yrs.
   ticar., erythema nodosum, bruis., arthralg., myalg., musc.cramps, oed.  Adults & adolesc. over 12 yrs: 2 sprays in each nostril once a
   Warnings and special precautions: . Monit. with concom.potent  10.6  Others  day. Maint: 1 spray in each nostril dly. once adeq.control achiev.
   hepat.enzyme induc.(eg phenytoin/ phenobarbit./rifampicin)/St Johns   Childr.2-11 yrs: 1 spray in each nostril once dly. Where respons.
   Wort/ potent hepat.enzyme inhibits.(eg. ketoconazole/ itraconazole/   DAXAS, Astra Zeneca [P/S]  inadeq.admin.2 sprays in each nostril.once dly. Reduc.to1 spray in
   voriconazole), take contin. dur.contr.periods & dur.periods of worsen.,   Roflumilast  each nostril dly. once adeq.control achiev.
   can be add.to exist.treatm.regimen, physic.should be alert to poss.  Indications: Maint.treatm.of mod.to sev.chron. obstruct.pulm.dis.  Side effects: Very comm: Epistax. Comm: Nas.ulcerat.
   eosinophil./vasculit.rash/worsen. of pulm.sympts./card.complicats.&   assoc.with chron.bronchit.in pts. at risk of exacerbat.  Warnings and special precautions: Transf.of pts. from syst.ster-
   neuropathy, effic. for treat.ac.asthma att.not est., pt.to seek medic   (S4) TABS, 44/10.3/0670  oid.if adren.funct. impairm. suspect., concom.ritonavir not recomm.,
   advice if current short-act bronchodilat.no long. adeq.or more than   715321-002: 500 µg, 30, R579,73  not data avail. in sev.hepat.impairm., syst.effs.poss at high dos. & pro-
   max.inhalat.reqd., not for monother.for exerc.induc.bronchosp., not   Dosage: 500 µg once dly.  long use, monit.height in childr.receiv. prolong ther., safety in pregn.&
   for bronchosp. revers.in ac. asthma attacks incl.status asthmatic.,   Contraindications: Mod and sev.hepat.impairm., pregn. & lactat.,   lactat.not est., clinic. adren.suppress.poss.at high.than recomm.
   appropr.rescue meds.to be avail., grad. withdr.of exist.corti-coster.  childr.& adolesc.und.18 yrs., lact. intol./malabsorpt.  dos., admin.low.dos. at which effect. contr.of rhinit.sympts.maintain
   ther.und.medic. supervis., do not abrupt.substit.for inhal./other oral   Side effects: Hypersens., gynaecomast., weight decr., decr.appetite,   Interactions: Ritonavir poss.incr.system.expos.
   corti-coster., pts.sens.to aspirin to contin.avoid NSAID’s, tabs.contain   insom., anx., depress., nervousn., headache, trem., vertigo, dysgeus.,   See also MDR page 355.
   mannitol which may have laxat. eff., chew.tabs.not stud.in season.  palpitat., RTI, GI disturbs., incr.Gamma-GT/AST, skin rash, urticar.,   BECLATE AQUANASE, Cipla Medpro [P/S]
   allerg. rhinit. in childr.with asthma  musc.spasm, myalg., back pain, malaise, fatig.  Beclomethasone dipropionate.
   Interactions: Decr.AUC with phenobarb.  Special precautions: Not for ac.bronchosp. relief, clinic.stud.not
                                conduct.in immunocomprom./ ac. sev.infect.dis./Ca pts.except ba-  Indications: Treatm.of season.allerg.rhinit., incl. hayfev.
                                sal cell Ca & CHF NYHA grades 3&4, depress.hist.assoc.with sui-  (S2) AQUEOUS NAS.SPRAY, 30/21.5.1/0079.
                                cide ideat./behav., reproduct.toxic.in anim., excret. in lactat.rats milk.  820709-018: 50 µg/spray, 150 met.dos, R72,12
   10.4.3  Chromones            Drug interactions: Cytochrome P450 enzym. induc. may reduc.effic.  Dosage: Adults & childr.over 6 yrs: 50 µg in each nostril 2-4 xdly.
                                                              or 100 µg in each nostril 2xdly. Tot.dly.recomm.dos: 200-400 µg/day.
          No products listed                                  Contraindications: Untreat.fung.bact./vir. infects., TB, ocul.H Sim-
                                                              plex, unheal.nasal wounds, bleed.tendenc., hist.of recent nasal bleed.,
   10.4.4   Other anti-asthmatics  11   EAR, NOSE AND         childr. und.6 yrs., safety in pregn.not est.
                                                              Side effects: Nas.discomf., sneez., epistax., imp. wound heal., incr.
                                        THROAT                IOP, dry & irritat.of nose & throat, unpleas.taste & smell, epistax.
   ADCO-ZETOFEN, AI Pharm Ltd [P/S]                           Special precautions: Transf.of pts.from syst. steroids., period.
   Ketotifen hydrogen fumar.equiv.to ketotifen base           exam.of nas.mucosa for poss. chang., treat.infects.of nose & pharynx.
   Indications: Asthma prophylax., prophylax.& treatm.of allerg. 11.1   Topical nasal    BETNESOL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   rhinit.& skin reacts.                                      Betamethasone sod.phosph.
   (S2) SYRUP, 32/10.2.2/0619. 1 mg/5 ml  preparations        Indications: Hayfev.& vasomot.& non-season. allerg.rhinit.
   854905-006: 200 ml, R97,10                                 (S4) NOSE DROPS. H1257. 1 mg/ml.
   Dosage: Admin.2xdly.                                       708267-009: 5 ml, R191,04
   Childr: Und.14 kg (old.than 6 mnths.): 1,5 ml. 14-25 kg: 2,5 ml.
   Over 25 kg: 5 ml. Full therapeut.eff.may take sever. wks. If insuffic.  11.1.1   Antimicrobial and    Dosage: 2-3 drps 2-3 dly.in each nostril
                                                              Contraindications: Vir., bact., fung., TB & purul.infects., pregn., ul-
   respon.aft.4 wks., then dos.may be incr.grad./bm.          cerat.condit., rosacea, H.simplex, vaccinia/varicella
   Contraindications: Hepat.dis., safety in pregn. & lactat.not est.  combinations  Side effects: Dryn., irrit., epistax., ulcerat./ perforat. of nas.septum,
   Side effects: Sedat., dry mouth, dizz., drowsin., incr. appetit.,   smell & taste disturbs.
   weight gain.                 NASEPTIN, Glenmark [P/S]      Special precautions: Long term use in childr., infect. sympt.poss.
   Special precautions: Grad.withdr.of exist.anti-allerg.drugs., oral   Neomycin.sulph. 3250 iu, chlorhexidine HCl 1 mg/g.  mask., incr.suscept.to infect., adren.suppress.esp.in infts., grad.
   diabet.ther., supplem.treatm. with specif.anti-infect.therapy if inter-  Indications: Prophylax.& treatm.of nas.staph. infects.  withdr., HF, rec. MI, hypertens., diab.mellit., epilep., glauc., hypo-
   curr.infect. occurs, cont.with current anti-asthmat.agents for at least   (S4) CREAM, H1371  thyroid., hepat.fail., osteoporos., pept.ulcerat., psychos., sev.affect.
   2 wks.aft.start.long-term treatm.  826294-014: 15 g, R113,39  disords., ren.impairm.
   Drug interactions: Potent.eff.of sedat., hypnot., tranquill., narc.  Dosage: Apply 2-4xdly.  Drug interactions: Corticoster.eff.reduc.by barbitur./ carbamaz-
   analg., antihist., anticholin.& alcoh., revers.fall in thrombocyte count   Side effects: Skin sensitiv., ototox.  epine/phenytoin/primidone & rifampic., corticoster.plasma conc.
   with antidiabet. agents.     Special precautions: Avoid eyes & ears.  incr.by OC’s & ritonavir, corticoster.with K deplet.diuret.poss. caus.
                                                                               +
                                                                  +
   XOLAIR, Novartis South Africa (Pty) Ltd                    excess K loss & incr.hypokalaem.with amphotericin B/xanthines &
   See Section 24.1                                           ß2-agon., incr.GI bleed. & ulcerat.with concom.NSAID’s, alt. respons.
                                11.1.2  Glucocorticosteroids  to anticoags., poss.incr.antidiab./ antihypertens. requirem., salicyl.ser.
                                                              conc.decr., antimuscar. effs.in myasth.grav.poss.decr., poss. interacts
                                AVAMYS (MDR Listing)          with antivir./neuromusc.block.& fem. hormones.
   10.5   Surfactants           AEROMIDE, Forrester Pharma [P/S]  BETNESOL-N, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
                                Budesonide                    Betamethasone sod.phosph. 0,1 g, neomycin as sulph. 0,35 g/100 ml.
   CUROSURF, Safeline [P/S]     Indications: Season.& perennial allerg.rhinit. prophylax.  Indications: Hayfev., allerg.rhinit., ster.respons. inflamm.condits
   Poractant alfa               (S2) AQ.NAS.SPRAY 41/21.5.1/0238  where infect.is pres./suspect.
   Indications: Prophylact.treatm.of prem.newborn at risk of develop.  3000681-001: 100 µg/met.dos, 10 ml, R125,44  (S4) NOSE DROPS. H1258.
   RDS, treatm.of preterm babies over 700 g who have develop.RDS  Dosage: Adults & childr.over 12 yrs: Two sprays in each nostr.  708291-007: 5 ml, R138,75
   (S4) INTRATRACH.SUSP, 33/10.2.2/0528  once a day or one spray in each nostr 2xdly.morn.& even. Max.dly.  708429-009: 10ml, R277,51
   876054-009: 80 mg/ml, 1x1,5 ml vial, R6 110,20  dos.not to exceed 400 µg. Maint: Low.effect.dos.  Dosage: 2-3 drps 2-3xdly.in each nostril
   703493-003: 80 mg/ml, 1x3 ml vial, R12 220,38  Contraindications: Fung./ vir.nose infects., act./quiesc.pulm.TB,   Contraindications: Viral, fung., TB & purul. infects., perfor.eardrum,
   Dosage: Admin.direct.into the low.trachea, follow. each instillat.by   childr.und.12 yrs.  neonates, pregn., lactat.
   1 min.of man.ventilat.with inspir. O 2 conc.equiv.to that on the venti-  Side effects: Freq: mild.& trans.burn/dryn or other nas.irrit., dys-  Side effects: Ac.sensitisat.
   lat. reconnect. to the ventilat.at the same setting as bef. Then adjust   pon., Less freq: Nas./ oropharyng. candidias., hypersens., psychot.   Special precautions: Avoid unnecess./prolong. use, adren.sup-
   settings accord.to clinic.status & bld. gas analyses.  disord., aggress., depress., irritability, anx., dizzin., light-headedn.,   press.esp.in infts.
   Init.sngl.intratrach.dos.of 100-200 mg/kg (1,25-2,5 ml/kg). Furth.  glauc., incr.IOP, cataract, nas. crust., epistax., rhinorrh., nas.congest.,
   dos.of 100 mg/kg admin.at 12 hrly interv.poss.indicat.for infts.still   sneez., mucos. ulcerat., throat irrit., oropharyng. pain, dry throat,   FLIXONASE, (Aspen Pharmacare) GSK [P/S]
   intubat.& where RDS is consid.responsible for the persist/ dete-  cough, nas.sept.perforat., diarrh., N&V, dysgeus., dermatit., rash,   Fluticasone propionate.
   riorat. resp.status.         urticar., prurit., myalg., arthralg., lethargy, fatig. Freq. unknown:   Indications: Prophylax.& treatm.of season.& perenn. allerg.rhinit.
   Side effects: Poss.incr.in incid.of pulm. haemmorrh., trans.decr.  Anaphylact.react., hypercorticoidism, adren.suppress., childr.abnorm.  includ.hayfev.in adults, season. allerg.rhinit.in childr.4-11yrs.
   in brain electric.activ., assoc. haemodynam.changes may predis-  behav., nervousn., restlessn., headache, angioed., growth retardat.,   (S3) AQUEOUS NAS.SPRAY. X/21.5.1/359. 50 µg/spray
   pos. prems. to intracran.(periventricul.) haemorrh., early use in very   decr.bone density, thirst.  787795-003: 120 met.sprays/bottle, R255,58
   low birth-weight infts may be assoc. with poor.long-term neurode-  Warnings and special precautions: Inspect nas. mucosa reg.with   Dosage: Admin.by intranasal route only. For full therapeut.benef.reg.
   velopm.outcome.              contin.long-term treatm., poss. syst.effs.with prolong.high dos., poss.  use essent. Adults & childr. over 12 yrs: 2 sprays in each nostril
   Special precautions: Stabil.infts.gen.condit., optim. respon.  mask. of infect.signs/opportunist.infects & suppress. immune syst.,   once a day. Max: 2 sprays 2xdly in each nostril.
   may not be shown in infts.born aft. very prolong.rupt.of the membr.  init.anti-infect.ther.where necess., vir. infects., untreat.fung.& bact.  Season.allerg.rhinit.in childr.4-11yrs: 1 spray in each nostril once
                                resp.infects., HPA suppress. poss., tfd.from syst.to topic. corticos-  dly. Max.dly.dos. 2 sprays in each nostril. Safety & effic. not studied
   SURVANTA, Abbvie [P/S] &     ter., mod.liv.impairm., monit.height of childr. over 12 yrs. on prolong.  for periods long.than 4 wks.
   Total phospholipids (beractant).  ther., diab.melllit., osteoporos., pept.ulc.dis., vis.changes., glauc./   (S3) NASULES, 33/21.5.1/0329
   Indications: Neo-natal resp.distress syndr.  cataract hist., avoid in rec.nas.septum ulc./nas. surg./nas.trauma   Indications: Small to med.nas.polyps & assoc. sympts. of nas.
   (S1) LIQ. Z/10.2.2/211.      until heal.occur., cont.gluc., teratogen. in animals, cross.placenta &   obstruct.
   894184-008: 100 mg, 1x4 ml vial, R4 440,72  appears in breast milk,   878758-003: 400 µg/contain., 28 units, R445,74
   797928-006: 100 mg, 1x8 ml vial, R8 881,,44  Interactions: Effic.& syst.eff.enhanc.by oral/ parenteral corticos-  Dosage: Adults & adolesc.over 16 yrs: Instill cont.of 1 contain.
   Dosage: Warm bef.admin. Recom.dos: 100 mg phospholipid/kg   ter., ser.lev.poss.incr.by CYP3A3/4 inhibit.& decr.by CYP3A3/4 induc.,   into nose 1-2xdly.div.dos.betw. affect.nostrils.
   bm in vol.not exceed.4 ml/kg. Admin.as early as poss.prefer.babies   clear. decr.by cimetidine.  Contraindications: Pregn.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page199.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page195.html">195</a>&nbsp;&nbsp;&nbsp;<a href="page196.html">196</a>&nbsp;&nbsp;&nbsp;<a href="page197.html">197</a>&nbsp;&nbsp;&nbsp;<a href="page198.html">198</a>&nbsp;&nbsp;&nbsp;<a href="page199.html">199</a>&nbsp;&nbsp;&nbsp;<a href="page200.html">200</a>&nbsp;&nbsp;&nbsp;<a href="page201.html">201</a>&nbsp;&nbsp;&nbsp;<a href="page202.html">202</a>&nbsp;&nbsp;&nbsp;<a href="page203.html">203</a>&nbsp;&nbsp;&nbsp;<a href="page204.html">204</a>&nbsp;&nbsp;&nbsp;<a href="page205.html">205</a>
             </td>
             <td width="35%"><a href="page201.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page201.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
